stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Dow:  
Nasdaq:  
S&P 500:  
Nasus Pharma Ltd.NSRX
$3.073.76%-0.12

Nasus Pharma Ltd. (NSRX)

Date: 2026-10-30 16:00O: 3.23H: 3.27L: 3.07C: 3.07Vol: 4.889k
Nasus Pharma Ltd. stock is traded at $3.07, with a volume of 4,889. It is down -3.76% in the last 24 hours and down -16.80% over the past month.
Previous Close:
$3.19
Open:
$3.23
24h Volume:
4,889
Relative Volume:
0.25
Market Cap:
$35.96M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-12.03%
1M Performance:
-16.80%
6M Performance:
+13.70%
1Y Performance:
-60.54%
1-Day Range:
$0.00$0.00
1-Week Range:
$3.07$3.61
52-Week Range:
$1.98$9.50

Nasus Pharma Ltd. Stock (NSRX) Company Profile

Name
Nasus Pharma Ltd.
Phone
-
Address
Israel
Employee
7
X
-
Next Earnings Date
null
Latest SEC Filings
SEC
NSRX's Discussions on X
X

Compare NSRX vs LLY, JNJ, ABBV, MRK, NVS

StocksPriceMarket CapRevenueNet IncomeCash FlowEPS
NSRX
Nasus Pharma Ltd.
$3.07$35.96M$0$0$0$0.00
LLY
Lilly Eli Co
$1,417.54$1.26T$72.25B$25.28B$10.37B$27.78
JNJ
Johnson Johnson
$273.20$657.68B$97.93B$21.04B$17.80B$8.63
ABBV
Abbvie Inc
$294.89$521.11B$62.82B$3.60B$19.98B$2.03
MRK
Merck Co Inc
$149.52$368.89B$65.51B$8.93B$14.12B$3.55
NVS
Novartis Ag Adr
$160.79$303.67B$54.66B$13.58B$16.05B$7.02

Nasus Pharma Ltd. Stock (NSRX) Financials Data

There is no financial data for Nasus Pharma Ltd. (NSRX). Check out other stocks for more information.

Revenue

Chart is being upgraded

This chart will be back soon.

Net Income

Chart is being upgraded

This chart will be back soon.

Cash Flow

Chart is being upgraded

This chart will be back soon.

EPS

Chart is being upgraded

This chart will be back soon.

Nasus Pharma Ltd. Stock (NSRX) Insider Trading

  • Chief Executive Officer
    Transaction
    Buy
    Cost
    $3.76
    #Shares
    2,900
    Value ($)
    10,904
    #Shares Total
    156,991
  • Chief Executive Officer
    Transaction
    Buy
    Cost
    $2.04
    #Shares
    15,000
    Value ($)
    30,600
    #Shares Total
    21,246
Insider TradingRelationshipDateTransactionCost#SharesValue ($)#Shares Total
Teleman Dan BenjaminChief Executive OfficerApr 22 '26Buy$3.762,90010,904156,991
Teleman Dan BenjaminChief Executive OfficerMar 31 '26Buy$2.0415,00030,60021,246

Nasus Pharma Ltd. Stock (NSRX) Latest News

Oct 26, 2026
Oct 26, 2026
Oct 23, 2026
Oct 23, 2026
Oct 08, 2026
Oct 08, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 30, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 29, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 21, 2026
Sep 18, 2026
Sep 18, 2026
Sep 18, 2026
Sep 18, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 14, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 05, 2026
Sep 05, 2026
Sep 04, 2026
Sep 04, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Jul 28, 2026
Jul 28, 2026
Jul 28, 2026
Jul 28, 2026
Jul 28, 2026
Jul 28, 2026
Jun 26, 2026
Jun 26, 2026
Jun 09, 2026
Jun 09, 2026
May 26, 2026
May 26, 2026
May 22, 2026
May 22, 2026
May 01, 2026
May 01, 2026
May 01, 2026
May 01, 2026
May 01, 2026
May 01, 2026
Apr 17, 2026
Apr 17, 2026
Apr 22, 2026
Apr 22, 2026
Mar 26, 2026
Mar 26, 2026
Mar 25, 2026
Mar 25, 2026
Mar 25, 2026
Mar 25, 2026
Mar 16, 2026
Mar 16, 2026
Mar 16, 2026
Mar 16, 2026
Mar 09, 2026
Mar 09, 2026
Mar 09, 2026
Mar 09, 2026

Similar to NSRX